Burke Neurological Institute

What Burke Neurological Institute does

Burke Neurological Institute was a nonprofit research institute founded in 1978 and headquartered at 785 Mamaroneck Avenue, White Plains, NY. It described itself as the only research institute in the U.S. dedicated to finding treatments to repair the brain and spinal cord, and operated as an academic affiliate of Weill Cornell Medicine. The institute served individuals living with neurological conditions — stroke, spinal cord injury, traumatic brain injury, cerebral palsy, neurodegenerative diseases (including Alzheimer's), and retinal degenerative diseases — primarily by enrolling them in clinical trials and conducting translational neuroscience research. Faculty held dual appointments at Weill Cornell Medicine, and the institute was organized around specialized laboratories and centers including the Circuit Repair Laboratory, the Visual Plasticity and Repair Laboratory, the Center for Pain & Sensory Recovery, the Center for Vision Repair, and the Resilience Program.

The institute's research portfolio spanned neural circuit repair, axon regeneration, optogenetics, high-resolution confocal imaging, non-invasive brain stimulation (HF-rTMS and tDCS), robotic-assisted rehabilitation, cellular transplantation, gene therapy, and molecular studies. Notable proprietary methodologies included MAP2K/BRAF signaling activation to promote corticospinal axon regeneration, optogenetic characterization of retinal neurovascular circuits, a mobile-app-based stroke rehabilitation trial (DESTROKE), and an 18-session nerve transfer rehabilitation protocol for cervical spinal cord injury conducted in partnership with the Massachusetts General Paralysis Center. Products and services were clinical trials (stroke, SCI, TBI, cerebral palsy, neurodegenerative and retinal diseases), a Research Registry for prospective participants, educational programming including the Science Fuels Hope Webinar Series, and specialized research centers.

Burke's revenue model relied on NIH and NINDS federal research grants as the primary funding source, supplemented by philanthropic donations (including from the Baldoni family and the Burke Foundation) and participant compensation reimbursements within trials. The GTM motion was event-driven, recruiting participants through a toll-free line (1-844-NEURONY), email, website inquiry forms, and the Research Registry, while distributing research via the Weill Cornell Medicine academic network. Despite capturing a $45M NIH-funded Alzheimer's clinical trial in 2022, the institute faced chronic structural deficits — expenses exceeded revenue in 10 of 15 years — and ceased research operations on May 22, 2026, transferring its largest active trial to Weill Cornell Medicine while 45 employees and 10 principal investigators faced an uncertain future.

Name

Burke Neurological Institute

Legal name

Burke Neurological Institute

Website

https://burke.weill.cornell.edu

Company type

Private

Founded year

1978

Operating status

Closed

Headcount range

101–250 employees

Short description

Burke Neurological Institute was a nonprofit, Weill Cornell Medicine-affiliated neuroscience research institute in White Plains, NY, conducting clinical trials and translational research on brain and spinal cord repair for patients with stroke, spinal cord injury, TBI, cerebral palsy, and neurodegenerative and retinal diseases.

Ownership category

akta.pro rank

Product category

Neurological Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Neural & Spinal Cord Regeneration (HLAAAGAI)

akta.pro secondary industries

Neurology/CNS Gene Therapies (HLAAACAH), Movement Disorders (Parkinson’s, Tremor, Dystonia) (HLAKAIAC), Cognitive & Behavioral Neurology (Dementia/Memory Disorders) (HLAKAIAH), Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS) (HSADAIAC), Neurologic Rehabilitation Centers (Stroke/TBI/SCI/MS/Parkinson’s) (HLADAJAH)

Keywords

• Neurological repair research
• Clinical trials neurology
• Brain spinal cord injury
• Neurorehabilitation research
• Neuroscience clinical studies

Headquarters

HQ city

White Plains

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

1. NIH and federal research grants: Primary funding source includes major NIH-funded clinical trials (e.g., a $45 million NIH-funded Alzheimer's trial being transferred to Weill Cornell Medicine). NIH funding also supports specific research programs through NINDS, National Institute of Neurological Disorders and Stroke.
2. Philanthropic donations: The institute maintains a 'Donate' page and receives support from individual donors, families (e.g., the Baldoni family), and the Burke Foundation.
3. Clinical trial participant compensation: Participants in clinical trials receive compensation for study-related expenses such as travel and lodging, though this is a cost offset rather than revenue generation.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Burke Neurological Institute conducts neurological repair research and clinical trials targeting conditions such as stroke, spinal cord injury, traumatic brain injury, cerebral palsy, neurodegenerative diseases, and retinal degenerative diseases. As an academic affiliate of Weill Cornell Medicine, it translates laboratory neuroscience research into clinical treatments through specialized research centers, laboratories, and clinical trials conducted at its White Plains, NY campus.

Product overview

Burke Neurological Institute is an academic affiliate of Weill Cornell Medicine that translates groundbreaking research into clinical treatments to repair the brain and spinal cord. The institute operates as a unified research and clinical enterprise offering clinical trials across six neurological condition categories (stroke, spinal cord injury, traumatic brain injury, cerebral palsy, neurodegenerative diseases, and retinal degenerative diseases), supported by specialized research centers (Center for Pain & Sensory Recovery, Center for Vision Repair), a research registry for participant recruitment, and educational programs including the Science Fuels Hope Webinar Series. The institute's research is conducted through multiple specialized laboratories focused on neural circuit repair, molecular regeneration, motor recovery, and visual plasticity.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Trials Program

Quantifiable outcome

• HF-rTMS activated BRAF canonical effectors MAP2K1/2 and promoted CST axon regeneration and sprouting after spinal cord injury
• +2 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Five partnerships are on record, tiered minor and core.

• Stanford MedicineminorStrategic or Co-development Partner · 26 September 2025Stanford Medicine collaborated with Weill Cornell Medicine and Burke Neurological Institute on a study finding that skin-to-skin contact (kangaroo care) is associated with positive brain changes in preterm infants. The research analyzed 88 preterm infants.
• Weill Cornell MedicinecoreStrategic or Co-development PartnerBurke Neurological Institute is an academic affiliate of Weill Cornell Medicine. Faculty hold appointments at Weill Cornell Medicine, and a $45 million NIH-funded Alzheimer's clinical trial is being transferred to Weill Cornell Medicine. Research collaborations include co-authorship on publications and joint clinical trials.
• Massachusetts General Hospital — Paralysis Center (Dr. Justin Brown)coreStrategic or Co-development PartnerDr. Justin Brown, Director of the Massachusetts General Paralysis Center, performs nerve transfer surgeries for cervical spinal cord injury patients enrolled in Burke's clinical trial. He has performed more than 50 such procedures, many with excellent outcomes. Post-surgery rehabilitation is conducted at Burke Neurological Institute.
• Blythedale Children's Hospital — Burke-Blythedale Pediatric Neuroscience Research CollaborationcoreStrategic or Co-development PartnerA collaboration between Burke Neurological Institute and Blythedale Children's Hospital for pediatric neuroscience research. Dr. Dianna E. Willis served as Director of Research for this collaboration. The program aims to develop innovative treatments for children with neurological conditions including cerebral palsy.
• Cerebral Palsy Foundation — Scientific Advisory CouncilminorStrategic or Co-development PartnerDr. Kathleen M. Friel was invited to serve on the Scientific Advisory Council of the Cerebral Palsy Foundation, which guides the strategic direction of the Foundation's work to ensure innovation, relevance, and impact.

Scale indicators6 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• The Miami Project to Cure Paralysis: University of Miami Miller School of Medicine research center dedicated to spinal cord injury and neurological repair research, conducting both basic science and clinical trials. Closest direct peer given BNI's spinal cord injury focus and translational research model.
• Kennedy Krieger Institute: Johns Hopkins-affiliated nonprofit research and treatment institution focused on neurological disorders including cerebral palsy, spinal cord injury, and brain injury in children and adults. Operates with a similar academic affiliate + clinical trials model.
• Reeve Foundation Research Center: Christopher & Dana Reeve Foundation funds and conducts spinal cord injury research with a translational focus similar to BNI. Operates a research consortium and clinical trial network targeting neurological recovery and repair.
• Kessler Foundation: New Jersey-based nonprofit dedicated to rehabilitation research for spinal cord injury, traumatic brain injury, stroke, and multiple sclerosis. Operates both bench research and clinical trials with rehabilitation focus directly comparable to BNI's approach.
• Moss Rehabilitation Research Institute: Research division of Einstein Healthcare Network (now Jefferson Health) focused on neurorehabilitation including brain stimulation and robotics. Directly comparable translational research portfolio and is where former BNI Brain Stimulation lab director Dylan Edwards now serves as Director.

Broad incumbents

• Allen Institute for Brain Science: Large, well-funded nonprofit neuroscience research organization conducting basic and translational brain research. Operates at significantly greater scale with a similar nonprofit, grant-funded model focused on understanding and treating neurological conditions.
• Janelia Research Campus (HHMI): Howard Hughes Medical Institute's dedicated neuroscience research campus focused on fundamental brain function and disease. Comparable nonprofit research model with strong neuroscience focus and elite investigator-driven science.
• Salk Institute for Biological Studies: Elite nonprofit biological research institute with significant neuroscience research programs, including work on neural circuit function and neurodegeneration. Comparable nonprofit research model with independent investigator-driven labs and grant funding.
• Gladstone Institutes: UCSF-affiliated nonprofit biomedical research organization with major programs in neurological disease and neurodegenerative disorders. Comparable academic-affiliate model and translational neuroscience focus on Alzheimer's and related conditions.

Emerging players

• NeuroRestore: Swiss-based research and clinical center (linked to EPFL/CHUV) focused on spinal cord injury and neuromodulation therapies, including epidural electrical stimulation. Comparable translational research model targeting neurological recovery through novel stimulation approaches like BNI's HF-rTMS work.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/BurkeNeuroSci
• YouTubeburke.weill.cornell.edu/youtube
• Facebookfacebook.com/BurkeNeuroSci
• LinkedInlinkedin.com/company/burkeneurosci
• Instagraminstagram.com/burkeneurosci

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Burke Neurological Institute